Insys Ch. 11 Sale Of Controversial Drug OK'd With New Limits
By Vince Sullivan · September 19, 2019, 1:08 PM EDT
Insys Therapeutics Inc. received bankruptcy court approval Thursday in Delaware for a sale of its controversial pain medication Subsys after the buyer agreed to limit its marketing and distribution efforts to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login